The State of Sjögren’s is an annual professional event presenting the most recent information and research about Sjögren’s disease. This virtual event is open to all professionals working in the Sjögren’s field and/or caring for Sjögren’s patients. Providers from all specialties are welcome. Registration and further details for the event are below.
View the Recording of State of Sjögren’s 2024
All medical professionals and Sjögren’s researchers are welcome to view the recording of the 2024 State of Sjögren’s event to see presentations related to this year’s theme, “The Many Faces of Sjögren’s” and the difficult-to-diagnose patients.
Note: This conference is not intended for patients.
Click here to share your interest in viewing this event. Once reviewed, you wil…2024- State of Sjögren’s: The Many Faces of Sjögren’s
This year's topics focus on the heterogeneity of Sjögren's that contributes to the difficult diagnosis for our patients.
State of Sjögren's: The Many Faces of Sjögren's (← click here for downloadable version)
• Welcome
• Sjögren’s Foundation - 40 Years of Progress!
Janet Church, President & CEO of the Sjögren’s Foundation
• Program Overview
Alan Baer, MD, Moderator Chair
Sjögren’s Foundation Medical & Scientific Advisory Council Director
Sjögren’s Clinic, Johns Hopkins University
• Diagnosis: The Many Faces of Sjögren’s
Thomas Grader-Beck, MD
Johns Hopkins School of Medicine
• The Difficult-to-Diagnose Patient
Astrid Rasmussen, MD, PhD
Oklahoma Medical Research Foundation
• Q&A/Discussion
• International Nomenclature Initiative
Alan Baer, MD, Moderator
• On the Horizon: Research to Improve Diagnosis
Kathy Hammitt, MA, Moderator
VP of Medical & Scientific Affairs
Sjögren’s Foundation
- Athena Papas, DMD, PhD, Tufts University School of Dental Medicine
- Darise Farris, PhD, Oklahoma Medical Research Foundation
- David Wong, DMD, DMSc, University of California Los Angeles (UCLA)
• On the Horizon: First Therapies for Sjögren’s?
- Daniel Wallace, MD Professor of Medicine, Cedars-Sinai Medical Center
David Geffen School of Medicine Center at UCLA
• Q&A/Discussion
Alan Baer, MD, Moderator Chair
• Closing Remarks
Janet Church, President & CEO of the Sjögren’s Foundation
We are pleased to partner with National Jewish Health to provide our CME/CNE credits.
Accreditation and Credits
CME: 2.0 AMA PRA Category 1 Credits™
Physicians: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of National Jewish Health and the Sjögren’s Foundation. National Jewish Health is accredited by the ACCME to provide continuing medical education for physicians.
National Jewish Health designates this live activity for a maximum of 2.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CNE: 2.0 Nursing Contact hours
Registered Nurses: Provider approved by the California Board of Registered Nursing, Provider Number 12724, for 2.0 contact hours. Registered nurses must attend the full program to earn nursing contact hours. Partial credit will not be awarded.
Accreditation Test: Once the event is complete, the video and post test will be available on STEP (Sjögren's Training and Education Platform). Additionally, the State of Sjögren's video and test will be available as an enduring CME for one year after the event date.
Sjögren’s is a difficult to diagnose disease with a wide variety of symptom presentations. State of Sjögren’s is designed to help clarify diagnostic challenges, inform of treatment options, learn about new research, and mostly, how to help patients manage this disease with dignity. Specific learning objectives for the 2024 State of Sjögren’s are:
1. Recognize the resources available to support patients living with Sjögren’s Disease
2. Recognize how patients with Sjögren’s Disease present symptoms differently
3. Identify strategies to diagnose a Sjögren’s patient who may be anti Ro negative and even biopsy negative
4. Evaluate new research to improve diagnosis of Sjögren’s Disease
5. Review upcoming therapies indicated specifically for Sjögren’s Disease